TP53 and cancer: In cancer cells, its overexpression leads to the negative regulation of p53,12,13 FOXO3a,14 HIF1-α15 and a blockage of Bax translocation to the mitochondria.16 Thus, SIRT1 induces cancer cell survival, accumulation of DNA mutations and drug resistance.